Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)

NCT01456949 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.

NCT NCT01456949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01456949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
Lead sponsor
Medtronic Cardiac Ablation Solutions
Phase
Not applicable
Overall status
Completed
Start date
June 26, 2012
Completion date
November 30, 2017
Enrollment
402 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation (paf)